×
验证码:
换一张
忘记密码?
记住我
×
登录
中文版
|
English
中国科学院昆明植物研究所知识管理系统
Knowledge Management System of Kunming Institute of Botany,CAS
登录
注册
ALL
ORCID
题名
作者
学科领域
关键词
资助项目
文献类型
出处
收录类别
出版者
发表日期
存缴日期
学科门类
学习讨论厅
图片搜索
粘贴图片网址
首页
研究单元&专题
作者
文献类型
学科分类
知识图谱
新闻&公告
在结果中检索
研究单元&专题
植物化学与西部植物... [13]
共享文献 [1]
中国科学院东亚植物多... [1]
作者
罗晓东 [4]
郝小江 [2]
普诺·白玛丹增 [2]
孙汉董 [2]
赵勤实 [2]
耿长安 [1]
更多...
文献类型
期刊论文 [25]
发表日期
3111 [1]
2023 [3]
2022 [3]
2021 [3]
2018 [4]
2017 [1]
更多...
语种
英语 [16]
出处
FRONTIERS ... [3]
ACS NANO [1]
CANCER GEN... [1]
CANCER PRE... [1]
CHEMISTRY ... [1]
CHINESE JO... [1]
更多...
资助项目
收录类别
SCI [15]
IC [3]
资助机构
Higher Edu... [1]
NIH/NCI [R... [1]
National N... [1]
National N... [1]
National N... [1]
National N... [1]
更多...
×
知识图谱
KIB OpenIR
开始提交
已提交作品
待认领作品
已认领作品
未提交全文
收藏管理
QQ客服
官方微博
反馈留言
浏览/检索结果:
共25条,第1-10条
帮助
已选(
0
)
清除
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
提交时间升序
提交时间降序
作者升序
作者降序
期刊影响因子升序
期刊影响因子降序
题名升序
题名降序
WOS被引频次升序
WOS被引频次降序
发表日期升序
发表日期降序
ABT-263 enhances sorafenib-induced apoptosis associated with Akt activity and the expression of Bax and p21 (CIP1/WAF1) in human cancer cells1
期刊论文
出版物, 3111, 期号: 0, 页码: 1-35
作者:
Jingru Li
;
Yicheng Chen
;
Jiali Wan
;
Xin Liu
;
Chunrong Yu
;
Wenhua Li
Adobe PDF(1198Kb)
  |  
收藏
  |  
浏览/下载:245/1
  |  
提交时间:2017/07/24
Abt-263
Sorafenib
Combination Therapy
Cancer
Hepatic Stellate Celland Liver Microbiome-Specific Delivery System for Dihydrotanshinone I to Ameliorate Liver Fibrosis
期刊论文
ACS NANO, 2023, 卷号: 17, 期号: 23, 页码: 23608-23625
作者:
Niu,Xia
;
Meng,Yanan
;
Cui,Jinjin
;
Li,Rui
;
Ding,Xiao
;
Niu,Bingyu
;
Chang,Ge
;
Xu,Ning
;
Li,Guiling
;
Wang,Yucheng
;
Wang,Lulu
浏览
  |  
Adobe PDF(5563Kb)
  |  
收藏
  |  
浏览/下载:47/7
  |  
提交时间:2024/07/10
liver fibrosis
dihydrotanshinone I
hepaticstellate cells
vitamin A
cyclodextrin
liver microbiome
STRATEGY
THERAPY
TARGET
NANOPARTICLES
PATHWAY
Discovery of nontriterpenoids from the rot roots of Panax notoginseng with cytotoxicity and their molecular docking study and experimental validation
期刊论文
RSC ADVANCES, 2023, 卷号: 13, 期号: 16, 页码: 11037-11043
作者:
Shang,Jia-Huan
;
Qiao,Yi-Jun
;
Zhu,Hong-Tao
;
Wang,Dong
;
Yang,Chong-Ren
;
Zhang,Ying-Jun
浏览
  |  
Adobe PDF(521Kb)
  |  
收藏
  |  
浏览/下载:96/21
  |  
提交时间:2024/05/09
THERAPY
Induction of RIPK3/MLKL-mediated necroptosis by Erigeron breviscapus injection exhibits potent antitumor effect
期刊论文
FRONTIERS IN PHARMACOLOGY, 2023, 卷号: 14, 页码: 1219362
作者:
Guo,Xiuping
;
Li,Rui
;
Cui,Jinjin
;
Hu,Chujuan
;
Yu,Haoyang
;
Ren,Ling
;
Cheng,Yangyang
;
Jiang,Jiandong
;
Ding,Xiao
;
Wang,Lulu
浏览
  |  
Adobe PDF(7660Kb)
  |  
收藏
  |  
浏览/下载:89/23
  |  
提交时间:2024/05/09
Erigeron Breviscapus Injection
Dengzhanxixin
Erigeron Breviscapus (Vant
) Hand
-mazz
Colorectal Cancer
Necroptosis
Drug Resistance
Tumor-necrosis-factor
Colorectal-cancer
Natural Compounds
Scutellarin
Apoptosis
Proliferation
Macrophages
Migration
Invasion
Therapy
Editorial: Oxidative stress related to cellular metabolism in lung health and diseases
期刊论文
FRONTIERS IN PHARMACOLOGY, 2022, 卷号: 13, 页码: 1015423
作者:
Arunachalam, Karuppusamy
;
Anand, Krishnan
;
Palanisamy, Subramanian
;
Anathy, Vikas
浏览
  |  
Adobe PDF(526Kb)
  |  
收藏
  |  
浏览/下载:26/2
  |  
提交时间:2024/08/21
reactive oxygen species
oxidative stress
lung disease
respiratory illness
drug toxicity and therapy
OBSTRUCTIVE PULMONARY-DISEASE
PREVALENCE
ASTHMA
Polysaccharide Peptide Induced Colorectal Cancer Cells Apoptosis by Down-Regulating EGFR and PD-L1 Expression
期刊论文
IRANIAN JOURNAL OF PHARMACEUTICAL RESEARCH, 2022, 卷号: 21, 期号: 1, 页码: e123909
作者:
Lin Jian
;
He Zhicheng
;
Liu Shubai
浏览
  |  
Adobe PDF(3879Kb)
  |  
收藏
  |  
浏览/下载:33/2
  |  
提交时间:2024/08/21
Colorectal Cancer
Trametes Versicolor
EGFR
PD-L1
Polysaccharide Peptide
CORIOLUS-VERSICOLOR
SIGNALING PATHWAY
COLON-CANCER
T-CELLS
STATISTICS
THERAPY
Current Advances in Mechanisms and Treatment of Dry Eye Disease: Toward Anti-inflammatory and Immunomodulatory Therapy and Traditional Chinese Medicine
期刊论文
FRONTIERS IN MEDICINE, 2022, 卷号: 8, 页码: 815075
作者:
Ling, Jiawei
;
Chan, Ben Chung-Lap
;
Tsang, Miranda Sin-Man
;
Gao, Xun
;
Leung, Ping Chung
;
Lam, Christopher Wai-Kei
;
Hu, Jiang-Miao
;
Wong, Chun Kwok
浏览
  |  
Adobe PDF(786Kb)
  |  
收藏
  |  
浏览/下载:33/2
  |  
提交时间:2024/08/21
inflammation
signaling pathways
immunomodulatory therapy
traditional Chinese medicine
dry eye disease
CHRONIC INFLAMMATORY LESIONS
MEIBOMIAN GLAND DYSFUNCTION
OCULAR-SURFACE
OPHTHALMIC SOLUTION
TEAR FILM
SJOGRENS-SYNDROME
ORAL DOXYCYCLINE
MATRIX METALLOPROTEINASES
TOPICAL CORTICOSTEROIDS
CATARACT-SURGERY
Prostaglandin E1 Is an Efficient Molecular Tool for Forest Leech Blood Sucking
期刊论文
FRONTIERS IN VETERINARY SCIENCE, 2021, 卷号: 7, 页码: 615915
作者:
Zheng,Fenshuang
;
Zhang,Min
;
Yang,Xingwei
;
Wu,Feilong
;
Wang,Gan
;
Feng,Xingxing
;
Ombati,Rose
;
Zuo,Ruiling
;
Yang,Canju
;
Liu,Jun
;
Lai,Ren
;
Luo,Xiaodong
;
Long,Chengbo
收藏
  |  
浏览/下载:178/0
  |  
提交时间:2022/04/02
leech
blood-sucking
prostaglandin E1
anticoagulant
Haemadipsa sylvestris
MEDICINAL LEECH
PGE1
INFLAMMATION
THERAPY
PAIN
E-1
Structures/cytotoxicity/selectivity relationship of natural steroidal saponins against GSCs and primary mechanism of tribulosaponin A
期刊论文
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2021, 卷号: 210, 页码: 113068
作者:
Dai,Zhi
;
Liu,Hui
;
Wang,Bei
;
Yang,Dong
;
Zhu,Yan-Yan
;
Yan,Huan
;
Zhu,Pei-Feng
;
Liu,Ya-Ping
;
Chen,Hui-Cheng
;
Zhao,Yun-li
;
Zhao,Li-Xing
;
Zhao,Xu-Dong
;
Liu,Hai-Yang
;
Luo,Xiao-Dong
浏览
  |  
Adobe PDF(2630Kb)
  |  
收藏
  |  
浏览/下载:234/96
  |  
提交时间:2022/04/02
Steroidal saponins
Structure-activity relationship
Tribulosaponin A
Glioma stem cells
ROS
SMALL MOLECULES
CARDIAC-ARREST
STEM-CELL
IDENTIFICATION
THERAPY
BRAIN
OPPORTUNITIES
GLIOMA
TUMORS
NOX2
Neo-clerodane Diterpenoids with Hypoglycemic Effects in Vivo from the Aerial Parts of Salvia hispanica L.
期刊论文
CHEMISTRY & BIODIVERSITY, 2021, 卷号: 18, 期号: 9, 页码: e2100517
作者:
Fan,Min
;
Wang,Ting
;
Peng,Li-Yan
;
Huang,Jun-Shang
;
Wu,Xing-De
;
Wang,He-Yao
;
Zhao,Qin-Shi
浏览
  |  
Adobe PDF(1403Kb)
  |  
收藏
  |  
浏览/下载:236/39
  |  
提交时间:2022/04/02
Salvia hispanica
neo-clerodane diterpenoid
salvihispin H
type 2 diabetes mellitus
GLUCOSE-TOLERANCE
RISK-FACTORS
THERAPY